These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 8878022

  • 21. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M.
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D, Kagata Y, Ogata S, Tsuda H, Hatsuse K, Mochizuki H, Matsubara O.
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [Abstract] [Full Text] [Related]

  • 26. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002 Dec; 9(4):689-92. PubMed ID: 12066193
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver.
    Sasaki A, Kawano K, Aramaki M, Nakashima K, Yoshida T, Kitano S.
    J Surg Oncol; 1999 Feb; 70(2):103-8. PubMed ID: 10084653
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY, Wang HL, Hart J, Fleming D, Beard MR.
    Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL, Das KM, Fogt F, Burke M, Murakata LA.
    Oncol Rep; 2002 Oct; 9(6):1369-72. PubMed ID: 12375050
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW, Davila RM, Merenda G.
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [Abstract] [Full Text] [Related]

  • 38. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
    Vij K, Wang HL.
    Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
    [Abstract] [Full Text] [Related]

  • 39. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS, Cho P, Silverman JF, Liu Y.
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.